ArticleJournal of pharmaceutical policy and practice2025
Knowledge, attitude, perception, and self-reported confidence of community pharmacists towards pharmacogenomics services.
Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pharmacogenomics is used to optimise patient drug therapy. The role of community pharmacists in the implementation of pharmacogenomics services is emerging. This study evaluated the knowledge, attitude, perception, and self-reported confidence of community pharmacists towards pharmacogenomics services. Methods: A cross-sectional study was conducted among community pharmacists in Penang, Malaysia, using a self-administered, validated and pre-tested questionnaire. Data were collected from March 2022 to April 2022, and analysed using both descriptive and inferential analyses. Results: One hundred and ten questionnaires were included in this study (response rate 65.5%). Only 14.5% had previous pharmacogenomics training, but 56.4% indicated interest to attend future pharmacogenomics training. Overall, respondents have low knowledge of pharmacogenomics, with higher knowledge score observed among those with previous pharmacogenomics training (median score: 10.5 [7-15] vs 9.0 [1-16], Conclusion: Community pharmacists have a low knowledge, and a low self-reported confidence towards pharmacogenomics services. Previous pharmacogenomics training and interest in attending pharmacogenomics training was associated with higher knowledge, attitude, perception, and self-reported confidence scores. Training of community pharmacists, development of local pharmacogenomics guidelines and design of a workable reimbursement plan for pharmacogenomics services are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.